Coronavirus Relief & Omnibus Agreement Authorizes PAs to Receive Direct Payment Under Medicare
28 déc. 2020 12h51 HE
|
American Academy of PAs
Alexandria, VA, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AAPA commends Congress for passing legislation authorizing PAs to receive direct payment under Medicare as part of the Coronavirus Relief &...
Strata Report Reveals COVID-19 Impact on U.S. Healthcare Delivery
23 sept. 2020 08h50 HE
|
Strata Decision Technology, L.L.C.
CHICAGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- A comprehensive six-month study of patient and procedure volume at 275 hospitals by Strata Decision Technology (Strata) revealed the significant financial...
Free National Financial Resource Directory Connects People to the Resources They Need
14 sept. 2020 13h08 HE
|
Patient Advocate Foundation
Hampton, VA, Sept. 14, 2020 (GLOBE NEWSWIRE) -- With families nationwide in search of more resources to support themselves through difficult times, the Patient Advocate Foundation relaunched the...
Provectus Announces Presentation of Updated Data from Metastatic Uveal Melanoma Cohort of Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
01 juin 2020 09h00 HE
|
Provectus Biopharmaceuticals Inc.
Treatment refractory, immunologically cold, hepatic tumor type37% reduction and 83% stabilization of treated disease (2D-EASL)Overall survival of 11 months for checkpoint inhibition-naïve patients;...
Overall Hospital Visit Recovery Sluggish Despite Positive Upward Trends in Outpatient Visits
01 juin 2020 08h00 HE
|
TransUnion
CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Ongoing research from TransUnion Healthcare (NYSE: TRU) indicates overall hospital visit volumes continue to slowly recover, though hospital visit volumes...
Provectus Announces Publication of Updated Data from Metastatic Neuroendocrine Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
01 juin 2020 07h00 HE
|
Provectus Biopharmaceuticals Inc.
Treatment refractory, immunologically cold, hepatic tumor type50% reduction of treated disease; 83% stabilization of overall patient disease (RECIST)Median progression-free survival not reached (by CT...
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
21 mai 2020 06h30 HE
|
Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...
As Many States Resume Elective Procedures, Ongoing TransUnion Healthcare Research Indicates Hospital Visits May Have Hit Bottom
07 mai 2020 09h00 HE
|
TransUnion
CHICAGO, May 07, 2020 (GLOBE NEWSWIRE) -- As the world navigates the impacts of the COVID-19 pandemic, ongoing research from TransUnion Healthcare (NYSE: TRU) indicates hospital visit volumes...
Hospital Visits Down Sharply and Patients May Not Be in a Rush to Reschedule Appointments
24 avr. 2020 08h00 HE
|
TransUnion
CHICAGO, April 24, 2020 (GLOBE NEWSWIRE) -- The COVID-19 pandemic has been challenging for many healthcare providers, both for those who are located in “hot spots” as well as those located elsewhere...
AAPA Calls on Governors to Empower Physician Assistants in COVID-19 Fight
31 mars 2020 13h25 HE
|
American Academy of PAs
ALEXANDRIA, Va., March 31, 2020 (GLOBE NEWSWIRE) -- The American Academy of PAs (AAPA) is calling on governors in all states to waive physician supervision or collaboration requirements for PAs...